NASDAQ$RNA

Atrium Therapeutics Inc · Q1 2021 earnings

Q1 2021 earnings ·

Headline financials

Total Revenue

$2.7M

No prior period
Capital Expenditures

-$525K

No prior period
Free Cash Flow

-$24.4M

No prior period
Net Income

-$23.8M

No prior period
Operating Income

-$23.9M

No prior period
Gross Profit

$0.00

No prior period

Revenue & EPS history

Atrium Therapeutics Inc · Revenue · Quarterly

$2.7M

Q1 2021
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Revenue by segment

Atrium Therapeutics Inc · $19.6M total across 1 segment · Q1 2026

  • Reportable Segment
    $19.6M—

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro